Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 2Colitis, Ulcerative 2Colitis 2Carcinoma, Non-Small-Cell Lung 2Takayasu Arteritis 1Recurrence 1Melanoma 1Lung Neoplasms 1Inflammatory Bowel Diseases 1Crohn Disease 1

Interventions

Tea 3Polyethylene Glycols 3Infliximab 3MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2sodium phosphate 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1cabozantinib 1Surgical Tape 1Standard of Care 1Spectrum Analysis, Raman 1Specimen Handling 1Pneumococcal Vaccines 1Platinum Compounds 1Passive Cutaneous Anaphylaxis 1Papillomavirus Vaccines 1Oxygen 1Nivolumab 1Neomycin 1Narrow Band Imaging 1Morphine 1Metronidazole 1Medical Marijuana 1Laparoscopy 1Ipilimumab 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Inflammatory Bowel Diseases × CT-P13 × Clear all
NCT04646187 2025-01-06

FREE

University Medical Center Groningen

Phase 4 Enrolling by invitation
148 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡